Literature DB >> 10198745

Transient effusive-constrictive pericarditis due to chemotherapy.

T Woods1, B Vidarsson, D Mosher, J H Stein.   

Abstract

Commonly used chemotherapeutic agents, specifically cytarabine and daunorubicin, can cause effusive-constrictive pericarditis. We describe a case of transient effusive-constrictive pericarditis in a patient with acute myelogenous leukemia. This is the first case report of a patient with transient effusive-constrictive pericarditis due to chemotherapy.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10198745      PMCID： PMC6655903          DOI： 10.1002/clc.4960220414

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN： 0160-9289            Impact factor:   2.882


  8 in total

1.  Myopericarditis in a pregnant woman with acute promyelocytic leukemia.

Authors:  Andrew Oehler; Shimoli Shah
Journal:  J Cardiol Cases       Date:  2014-08-19

Review 2.  Effusive-constrictive pericarditis.

Authors:  Faisal F Syed; Mpiko Ntsekhe; Bongani M Mayosi; Jae K Oh
Journal:  Heart Fail Rev       Date:  2013-05       Impact factor: 4.214

3.  Acute pericarditis with transient constriction: surgical impetus must be contained.

Authors:  Andre C Marques; Daniela Calderaro; Pai C Yu; Danielle M Gualandro; Luiz Flávio Galvão Gonçalves; Alessandro W Mariani; Bruno Caramelli
Journal:  BMJ Case Rep       Date:  2009-02-26

Review 4.  Transient Constrictive Pericarditis: Current Diagnostic and Therapeutic Strategies.

Authors:  James Gentry; Allan L Klein; Christine L Jellis
Journal:  Curr Cardiol Rep       Date:  2016-05       Impact factor: 2.931

5.  Pericarditis associated with cytarabine therapy for acute myelocytic leukemia: a case report.

Authors:  Xia Yang; Wei Liu; Allie Lyons; Zaiwei Song; Suodi Zhai; Kai Hu
Journal:  Eur J Clin Pharmacol       Date:  2017-10-27       Impact factor: 2.953

6.  Presentation pattern and management of effusive-constrictive pericarditis in Ibadan.

Authors:  M A Salami; P O Adeoye; V O Adegboye; O A Adebo
Journal:  Cardiovasc J Afr       Date:  2012-05       Impact factor: 1.167

7.  COVID-19 vaccination in children and adolescents aged 5 years and older undergoing treatment for cancer and non-malignant haematological conditions: Australian and New Zealand Children's Haematology/Oncology Group consensus statement.

Authors:  Eliska Furlong; Rishi S Kotecha; Rachel Conyers; Tracey A O'Brien; Jordan R Hansford; Leanne Super; Peter Downie; David D Eisenstat; Gabrielle Haeusler; Brendan McMullan; Marianne B Phillips; Bhavna Padhye; Luciano Dalla-Pozza; Frank Alvaro; Christopher J Fraser; Wayne Nicholls; Julia E Clark; Matthew O'Connor; Benjamin R Saxon; Heather Tapp; John Heath; Sarah E Hunter; Karen Tsui; Mark Winstanley; Amanda Lyver; Emma J Best; Ushma Wadia; Daniel Yeoh; Christopher C Blyth; Nicholas G Gottardo
Journal:  Med J Aust       Date:  2022-03-10       Impact factor: 12.776

8.  Prevention of High-Dose Cytosine Arabinoside-Induced Acute Pericarditis with Preemptive Dexamethasone Administration: A Case Report and Literature Review.

Authors:  Weerapat Owattanapanich; Theera Ruchutrakool
Journal:  Case Rep Hematol       Date:  2018-02-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.